For Healthcare Professionals: Multimedia

Watch videos featuring Memorial Sloan Kettering experts discussing new treatment approaches, key clinical trials, and innovations in detecting and treating many cancers.

Introduction to Spinal Tumor Diagnosis and Classification and Review of Intradural Tumors

Neurosurgeon Mark Bilsky describes new approaches to diagnosing and treating spine tumors.

Runtime: 40:00 minutes Published: 12/05/2014 - 10:15 AM
Conventional and Stereotactic Radiation Therapy

Radiation oncologist Yoshiya Yamada describes various radiotherapy techniques to treat spinal tumors.

Runtime: 28:00 minutes Published: 12/05/2014 - 10:14 AM
Metastatic Tumors of the Mobile Spine

Neurosurgeon Ilya Laufer describes considerations in choosing surgery or treatment for patients with spine tumors.

Runtime: 24:00 minutes Published: 12/05/2014 - 10:11 AM

Radiation oncologist Yoshiya Yamada discusses the benefits of brachytherapy for spine tumors.

Runtime: 15:30 minutes Published: 12/05/2014 - 10:00 AM
Case Study: WT1-Specific T-Cell Responses in a Patient with Plasma Cell Leukemia and Relapsed Refractory Multiple Myeloma

Medical oncologist Guenther Koehne explains how remission was achieved using WT1-specific T-cell therapy in a patient with refractory multiple myeloma and plasma cell leukemia.

Runtime: 05:00 minutes Published: 04/17/2014 - 11:39 AM
Robotic Surgery for Gynecologic Cancers

Co-Director of Robotic Surgery Mario Leitao, Jr., describes the emerging role and clear benefits of the robotic platform for operating on gynecologic cancers.

Runtime: 05:30 minutes Published: 04/17/2014 - 10:37 AM
Laser Surgery for Early-Stage Laryngeal Cancers: Standards of Care in the OR

Head and Neck Surgeon Ian Ganly describes the value of transoral laser surgery as an alternative to radiation therapy for resection of early-stage laryngeal cancers.

Runtime: 03:00 minutes Published: 04/02/2014 - 11:59 AM
Artemis Imaging Technology: A New Standard of Care in the Operating Room?

Memorial Sloan Kettering physicians discuss the power and potential of a new nanotechnology-based optical imaging system, the Artemis camera, to help guide cancer surgeries.

Runtime: 04:00 minutes Published: 02/27/2014 - 5:24 PM
Combination Therapy for Patients with Untreated Advanced GIST

Medical oncologists William Tap and Ping Chi describe an investigational combination therapy for untreated advanced gastrointestinal stromal tumors.

Runtime: 04:00 minutes Published: 12/11/2013 - 2:33 PM
Novel Agents Targeting the Androgen Receptor in Castration-Resistant Prostate Cancer

Medical oncologist Dana Rathkopf discusses therapies for metastatic prostate cancer that target the androgen receptor.

Runtime: 3:00 minutes Published: 09/24/2013 - 4:34 PM
Hyperthermic Intraperitoneal Chemotherapy for Cancers of the Appendix, Colon, or Rectum

Memorial Sloan Kettering surgeons describe a phase II trial comparing agents administered through HIPEC for cancers of the appendix, colon, and rectum.

Runtime: 2:00 minutes Published: 09/24/2013 - 3:56 PM
Hyperthermic Intraperitoneal Chemotherapy for Ovarian Cancer

Gynecologic oncologist Oliver Zivanovic describes the use of heated intraperitoneal chemotherapy to treat ovarian cancer.

Runtime: 03:00 minutes Published: 08/13/2013 - 3:16 PM
Prostate-Specific PET Scans

Medical oncologist Michael Morris describes a technique developed at Memorial Sloan Kettering to image prostate cancer metastases via PET scan.

Runtime: 02:00 minutes Published: 07/08/2013 - 11:51 AM
Radiopharmaceuticals for Prostate Cancer

Medical oncologist Michael Morris describes noninvasive radiopharmaceuticals for prostate cancer–related bone metastases.

Runtime: 02:00 minutes Published: 07/08/2013 - 11:36 AM
Glomus Tumor at Tracheal Carina

Thoracic surgeon Robert Downey describes the diagnosis and treatment of a rare glomus tumor situated at the tracheal bifurcation in a male marathon runner.

Runtime: 04:00 minutes Published: 07/05/2013 - 3:14 PM
CD19-Targeted T Cells Rapidly Induce Remissions in Acute Lymphoblastic Leukemia

Medical oncologist Renier Brentjens describes an innovative therapy to modify T cells to recognize the CD19 protein.

Runtime: 05:00 minutes Published: 06/18/2013 - 11:57 AM
Herb-Drug Interactions in Cancer Care

The majority of cancer patients use complementary therapies such as herbs and dietary supplements. Although figures differ, surveys indicate that as many as 60 percent of people with cancer take two or more dietary supplements daily.

Published: 06/13/2013 - 10:23 AM
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Gynecologic oncologist Dennis Chi describes a clinical trial evaluating secondary cytoreduction with and without HIPEC for various malignancies.

Runtime: 03:00 minutes Published: 04/17/2013 - 2:14 PM
Treating CMV Reactivation Following Allogeneic Bone Marrow Transplant

Physician-scientist Guenther Koehne, Medical Director of the Cytotherapy Laboratory, explains a therapy that uses sensitized T cells to treat resistant CMV infection in allogeneic stem cell transplant recipients.

Runtime: 04:00 minutes Published: 04/03/2013 - 9:07 AM
Combining Immunotherapy with Isolated Limb Infusion in Treating Advanced Melanoma

Surgical oncologist Charlotte Ariyan explains a new treatment approach being explored for patients with advanced melanoma.

Runtime: 03:00 minutes Published: 03/07/2013 - 2:55 PM
IL-7 Promotes T Cell Recovery after Allogeneic Stem Cell Transplantation

Medical oncologists Marcel van den Brink and Miguel-Angel Perales describe results of a phase I trial of IL-7 in stem cell transplantation.

Runtime: 03:00 minutes Published: 02/19/2013 - 1:19 PM
Regulation of Intestinal Inflammation by Microbiota following Allogeneic Bone Marrow Transplantation

Medical oncologist Robert Jenq describes the role of microbiota in regulating intestinal inflammation post-allogeneic bone marrow transplant.

Runtime: 03:00 minutes Published: 02/19/2013 - 9:36 AM
Extrathymic Development of Murine T Cells Post–Bone Marrow Transplant

Medical oncologist Marcel van den Brink describes research indicating that functioning T cells may be generated in abdominal (mesenteric) lymph nodes.

Runtime: 03:00 minutes Published: 02/19/2013 - 9:28 AM
Predictor of Transplantation Failure in Relapsed and Refractory Follicular Lymphoma (2012 ASH Conference)

Fellow Matthew Lunning describes a retrospective study that examined event-free and overall survival among patients with relapsed/refractory follicular lymphoma.

Runtime: 03:00 minutes Published: 12/10/2012 - 1:11 PM
Donor-Recipient Matching of Unrelated Cord Blood Units (2012 ASH Conference)

Fellow Parastoo Dahi describes study results indicating that higher resolution HLA matching is possible without significantly compromising graft dose in unrelated cord blood transplantation.

Runtime: 03:00 minutes Published: 12/10/2012 - 9:16 AM
Graft-Specific HLA Antibodies in Double-Unit Cord Blood Transplantation (2012 ASH Conference)

Fellow Parastoo Dahi reviews a study that found that that graft-specific HLA antibodies do not influence unit dominance or prevent high rates of sustained donor engraftment in double-unit cord blood transplantation.

Runtime: 02:00 minutes Published: 12/10/2012 - 9:15 AM
Adjuvant Therapies in Gastric Cancer

Medical oncologist David Ilson talks about advances in adjuvant therapies for gastric cancer in a Grand Rounds presentation.

Runtime: 34:00 minutes Published: 11/12/2012 - 10:51 AM
Advances in Gastric Cancer

Gastric surgeon Vivian Strong talks about improved staging, progress in surgical technologies, and other advances in gastric cancer treatment in this Grand Rounds presentation.

Runtime: 26:00 minutes Published: 11/12/2012 - 10:44 AM
Phase III Trial for Patients with Myelodysplastic Syndromes and Symptomatic Anemia

Medical oncologist Virginia Klimek discusses a multicenter Phase III randomized clinical trial for MDS patients with symptomatic anemia.

Runtime: 04:00 minutes Published: 11/01/2012 - 10:07 AM
Phase I Clinical Trial of Anti-PD-1 in Hematologic Malignancy

Medical oncologist Alexander Lesokhin discusses a phase I dose escalation of an anti-PD-1 immunotherapy in patients with hematologic cancers.

Runtime: 03:00 minutes Published: 10/01/2012 - 8:42 AM
Minimally Invasive Techniques for Managing Early- and Late-Stage Ovarian Cancer

Gynecologic oncologist Dennis Chi reviews the use of minimally invasive techniques such as laparoscopy for the surgical staging of ovarian cancer.

Runtime: 04:00 minutes Published: 10/01/2012 - 8:36 AM
Improving Outcomes by Changing the Surgical Paradigm for Optimal Debulking

Gynecologic oncologist Dennis Chi discusses significant improvements in advanced ovarian cancer cases through the incorporation of extensive upper abdominal procedures.

Runtime: 03:00 minutes Published: 09/19/2012 - 11:30 AM
Phase III Clinical Trial of Doxorubicin Alone or in Combination with TH-302

Medical oncologist William Tap discusses a multicenter randomized study that compares doxorubicin plus TH-302 versus doxorubicin alone for locally advanced soft tissue sarcoma that is inoperable or metastatic.

Published: 09/04/2012 - 12:36 PM
Vascular Targeted Photodynamic Therapy for Prostate Tumors

Urologic surgeon Jonathan Coleman discusses vascular targeted photodynamic (VTP) therapy for delivering intravenous TOOKAD® to destroy prostate tumors and the blood vessels that support them.

Runtime: 01:53 minutes Published: 08/15/2012 - 1:18 PM
Irreversible Electroporation (NanoKnife®) to Treat Prostate Tumors

Urologic surgeon Jonathan Coleman discusses an irreversible electroporation, a focal therapy that employs a NanoKnife® device to deliver an electrical current to small, localized prostate tumors.

Runtime: 02:30 minutes Published: 08/15/2012 - 1:15 PM
Thermal Prostate Tumor Ablation via Interstitial Laser Therapy

Urologic surgeon Jonathan Coleman discusses interstitial laser therapy, a thermal focal therapy option in which laser energy delivered with precision destroys small prostate tumors.

Runtime: 03:36 minutes Published: 08/15/2012 - 1:12 PM
Focal Cryoablation as Prostatectomy Alternative

Urologic surgeon Jonathan Coleman discusses focal cryoablation to destroy small and localized prostate tumors.

Runtime: 02:01 minutes Published: 08/15/2012 - 1:10 PM
Prostate Cancer Treatment via Focal Therapies

Urologic surgeon Jonathan Coleman discusses novel forms of focal therapy that may benefit select patients with localized prostate cancer.

Runtime: 03:49 minutes Published: 08/15/2012 - 1:07 PM
Minimally Invasive Approaches for Treating Kidney Tumors

Urologic surgeon Jonathan Coleman discusses approaches and techniques that have enabled surgeons to perform many kidney procedures in a less invasive manner.

Runtime: 04:07 minutes Published: 08/15/2012 - 1:02 PM
Personalizing Treatment: Mutations Identified in Squamous Cell Lung Cancer Tumors

Medical oncologist Paul Paik discusses the Squamous Cell Carcinoma of the Lung Mutation Analysis Program (SQ-MAP) and various open clinical trials.

Runtime: 04:00 minutes Published: 06/05/2012 - 3:14 PM
Sentinel Lymph Node Mapping in Gynecologic Cancers

Gynecologic oncologist Nadeem Abu-Rustum discusses the prognostic and therapeutic power of sentinel lymph node mapping in gynecologic cancers.

Runtime: 05:00 minutes Published: 05/01/2012 - 12:09 PM
Clinical Trial: Study of Oral Sapacitabine in Elderly Patients with Newly Diagnosed AML

Hematologist-oncologist Ellin Berman discusses a randomized phase III clinical trial of an investigational oral drug, sapacitabine, for AML in elderly patients.

Runtime: 03:00 minutes Published: 05/01/2012 - 10:13 AM
Clinical Trial: BMS-906024 for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia and T-Cell Lymphoblastic Lymphoma

Hematologist-oncologist Don Douer discusses a Phase I clinical trial of intravenous BMS-906024.

Runtime: 02:00 minutes Published: 05/01/2012 - 10:03 AM
Complementary Therapies for Pain Management

Integrative medicine physician Gary Deng discusses complementary therapies for managing chronic pain.

Runtime: 28:00 minutes Published: 04/01/2012 - 9:38 AM
Integrated Genetic Profiling in Acute Myelogenous Leukemia

Mutational profiling can improve risk stratification and inform prognostic and therapeutic decisions regarding patients with AML.

Runtime: 03:00 minutes Published: 03/21/2012 - 3:26 PM
Unique Cases: The Use of Fluorescent Dye in Sentinel Lymph Node Mapping

Gynecologic oncologist Elizabeth Jewell discusses the fluorescent dye surgical platform in sentinel lymph node mapping for cervical and endometrial cancer detection.

Runtime: 04:00 minutes Published: 03/01/2012 - 11:06 AM
Grand Rounds on the Role of Integrative Medicine in Oncology

Integrative Medicine Service Chief Barrie Cassileth describes the program at Memorial Sloan Kettering Cancer Center that has served as a model for similar services around the world.

Runtime: 37:00 minutes Published: 02/17/2012 - 8:47 AM
Grand Rounds Presentation on Curing Rectal Cancer

Gastrointestinal Oncology Service Chief Leonard Saltz talks about advances in the personalized treatment and cure of rectal cancer in this Grand Rounds presentation.

Runtime: 54:00 minutes Published: 01/24/2012 - 7:30 AM
Cord Blood Transplantation for Hematologic Malignancies: Improving Access and Outcomes

Cord blood extends access to transplants for the majority of patients.

Runtime: 04:00 minutes Published: 01/10/2012 - 1:51 PM
Treating Liver Metastases with Hepatic Arterial Infusion Therapy

Medical oncologist Nancy Kemeny reviews evidence for HAI in extending survival and improving quality of life for patients with colorectal cancer and liver metastases.

Runtime: 08:00 minutes Published: 01/09/2012 - 1:41 PM
Developing New Treatments for T Cell Lymphoma

Medical oncologist Steven M. Horwitz discusses the development and impact of three new, widely used therapies for T cell lymphoma: pralatrexate, romidepsin, and brentuximab vedotin.

Runtime: 05:00 minutes Published: 12/27/2011 - 10:48 AM
Role of FDG PET, CT, and Bone Marrow Biopsy (2011 ASH Conference)

Chief of the Lymphoma Service Andrew Zelenetz discusses a retrospective review examining the frequency of FDG avidity across a range of lymphoma histologies.

Runtime: 03:00 minutes Published: 12/10/2011 - 10:47 AM
Pegylated Liposomal Doxirubicin in Cutaneous T Cell Lymphoma (2011 ASH Conference)

Medical oncologist David Straus discusses how sequential bexarotene does not increase response rate in patients with Kaposi’s sarcoma.

Runtime: 02:00 minutes Published: 12/10/2011 - 10:42 AM
Romiplostim in Chemotherapy-Induced Thrombocytopenia (2011 ASH Conference)

Gerald Soff, Chief of Memorial Sloan Kettering’s Hematology Service, describes the use of weekly romiplostim in patients with prolonged isolated thrombocytopenia.

Runtime: 02:00 minutes Published: 12/10/2011 - 10:35 AM
Bexxar/BEAM Versus Rituximab/BEAM and Autologous Stem Cell Transplantation (2011 ASH Conference)

Clinical Director of the Division of Hematologic Oncology Craig Moskowitz discusses a study comparing conditioning regimens followed by autologous stem cell transplantation.

Runtime: 02:00 minutes Published: 12/10/2011 - 10:31 AM
Allogeneic Transplant Following Brentuximab Vedotin Treatment (2011 ASH Conference)

Clinical Director of the Division of Hematologic Oncology Craig Moskowitz discusses positive responses of brentuximab vedotin in patients with Hodgkin lymphoma and systemic ALCL.

Runtime: 02:00 minutes Published: 12/10/2011 - 10:17 AM
Ofatumumab with ICE or DHAP Chemotherapy in B Cell Lymphoma (2011 ASH Conference)

Medical oncologist Matthew Matasar discusses the inclusion of OFA in second-line therapy for aggressive or relapsing B-cell non-Hodgkin’s lymphoma.

Runtime: 02:00 minutes Published: 12/10/2011 - 10:12 AM
WT1-Specific Immune Responses in Multiple Myeloma (2011 ASH Conference)

Medical Director of the Cytotherapy Laboratory Guenther Koehne discusses WT1-specific cellular immune responses in patients with relapsed multiple myeloma and high-risk cytogenetics.

Runtime: 01:00 minutes Published: 12/10/2011 - 10:04 AM
Patterns of Disease Relapse and Progression in Multiple Myeloma (2011 ASH Conference)

Medical oncologist Hani Hassoun reviews a study that examined patterns of post-ASCT relapse.

Runtime: 02:00 minutes Published: 12/10/2011 - 9:51 AM
Predicting Incidence of Dose Limiting Toxicities in Lymphoma Trials (2011 ASH Conference)

Clinical Director of the Lymphoma Outpatient Unit Paul Hamlin discusses relationship between DLT and SAE with increasing age and comorbidities in lymphoma trials.

Runtime: 01:00 minutes Published: 12/10/2011 - 9:43 AM
Late Relapses following ATRA for APL are Uncommon (2011 ASH Conference)

Leader of the Acute Lymphoblastic Leukemia Program Dan Douer discusses a study examining late relapses among APL patients.

Runtime: 02:00 minutes Published: 12/10/2011 - 9:36 AM
ASXL1 Mutations Promote Myeloid Transformation (2011 ASH Conference)

Medical oncologist Omar Abdel-Wahab discusses studies that assessed the functional implications of ASXL1 mutations in the hematopoietic compartment.

Runtime: 01:00 minutes Published: 12/10/2011 - 9:30 AM
SCI-33 Epigenetic Effects of IDH1/IDH2 Mutations (2011 ASH Conference)

Medical oncologist Omar Abdel-Wahab discusses data linking TET2 with the function of cytosine deaminases as a pathway toward DNA demethylation.

Runtime: 01:00 minutes Published: 12/10/2011 - 9:25 AM
Validation of a High-Risk MDS Prognostic Model (2011 ASH Conference)

Medical oncologist Omar Abdel-Wahab discusses a study that validates a lower-risk prognostic scoring system’s ability to identify higher-risk MDS patients.

Runtime: 01:00 minutes Published: 12/10/2011 - 9:04 AM
Improving Outcomes Using Stereotactic Radiosurgery

Neurosurgeon Mark Bilsky, MD, explains how stereotactic radiosurgery has dramatically improved outcomes for patients with spine tumors.

Runtime: 03:00 minutes Published: 11/30/2011 - 3:11 PM
Arsenic Trioxide as Initial Therapy for Acute Promyelocytic Leukemia

Martin Tallman, a hematologist-oncologist at Memorial Sloan Kettering, discusses a clinical trial combining arsenic trioxide with all-tansretinoic acid (ATRA) for the treatment of patients with APL.

Runtime: 3:00 minutes Published: 09/14/2011 - 12:00 AM
Leading-Edge Image-Guided Techniques

Stephen Solomon, Chief of the Interventional Radiology Service, discusses techniques used at our state-of-the-art Center for Image Guided Intervention—from minimally invasive biopsies to palliative procedures.

Runtime: 6:00 minutes Published: 09/14/2011 - 12:00 AM
Leading Edge Options for the Treatment of Bladder Cancer

Urologic surgeon Bernard Bochner discusses the prevalence of bladder cancer in the United States, and novel approaches to treatment.

Runtime: 6:00 minutes Published: 07/01/2011 - 12:00 AM
Animation of Cell-based, Targeted Immunotherapy

Animated video shows how Memorial Sloan Kettering researchers are using genetically engineered T-cells to recognize and attack cancer.

Runtime: 1:00 minutes Published: 05/01/2011 - 12:00 AM
Immune-based Gene Therapy for Cancer

MSKCC scientists are engineering immune-system cells called T cells so that they can identify and destroy leukemia and prostate cancer cells.

Runtime: 6:00 minutes Published: 05/01/2011 - 12:00 AM
Development of Next Generation Anti-Androgens

Medical oncologist Howard Scher describes new anti-androgen therapies for prostate cancer that returns after hormone therapy.

Runtime: 4:00 minutes Published: 03/01/2011 - 12:00 AM
New Treatment Paradigm for Advanced Renal Cell Carcinoma

Medical oncologist Robert Motzer discusses significant treatment advances and improved prognosis for patients with advanced renal cell carcinoma.

Runtime: 6:00 minutes Published: 03/01/2011 - 12:00 AM
Clinical Decisions in the Management of Prostate Cancer

Surgeon James Eastham talks about quality-of-life issues associated with treatments for prostate cancer.

Runtime: 4:00 minutes Published: 02/01/2011 - 12:00 AM
Clinical Trials in Neoadjuvant Therapy for Bladder Cancer

Medical oncologist Dean Bajorin describes novel chemotherapy drugs in development at Memorial Sloan Kettering that may be given before bladder cancer surgery.

Runtime: 5:00 minutes Published: 02/01/2011 - 12:00 AM
Treatment Strategies for Muscle Invasive Bladder Cancer

Medical oncologist Dean Bajorin talks about combining chemotherapy or radiation with surgery to treat patients with advanced bladder cancer.

Runtime: 2:00 minutes Published: 02/01/2011 - 12:00 AM